This is a preview of subscription content, log in via an institution to check access.
Reference
Lu L, et al. Cost effectiveness of oromucosal cannabis-based medicine (Sativex) for spasticity in multiple sclerosis. PharmacoEconomics 30: 1157-1171, No. 12, 2012
Rights and permissions
About this article
Cite this article
Does Sativex make the grade for spasticity in MS?. PharmacoEconomics & Outcomes News 668, 6 (2012). https://doi.org/10.1007/s40274-012-0018-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-012-0018-6